Large employer health plans will now be required to cover in-patient hospitalization services, according to a notice from the Treasury Department and HHS on Tuesday morning. The final regulation will be issued next year.
Large employer health plans will now be required to cover in-patient hospitalization services, according to a notice from the Treasury Department and HHS on Tuesday morning. The final regulation will be issued next year.
The administration’s move will close a loophole that affected millions. Now, large employer plans lacking hospital coverage will not meet standards under the Affordable Care Act.
“The Departments believe that plans that fail to provide substantial coverage for in-patient hospitalization services or for physician services (or for both) … do not provide the minimum value intended by the minimum value requirement,” according to the notice.
Plans that do not include “substantial coverage” for hospitalizations will not be considered as providing minimum value, according to HHS’ intended proposal. Employers who enrolled workers in plans excluding hospitalizations before November 4 will be allowed for a year.
According to Kaiser Health News (KHN), analysts had assumed that the minimum value calculator, which tests whether or not insurance pays at least 60% of expected medical costs, would require hospital care; however, that is not the case.
Large employers that do not offer minimum value coverage next year could be fined up to $3120 per worker, KHN reported.
The American Hospital Association (AHA) had previously expressed concerns to CMS about the issue, and hailed the administration’s decision to require large employer health plans cover hospitalizations.
“Hospitals were alarmed that plans could offer health insurance that did not include inpatient hospital benefits,” Rich Umbdenstock, president and chief executive officer of AHA, said in a statement. “Comprehensive inpatient hospital coverage is critical.”
However, so-called “skinny plans” will not be required to cover hospital care. These plans are offered by lower-wage firms, such as retailers and staffing companies, and do not include much else more than preventive care benefits. These skinny plans still provide a minimum essential coverage, according to KHN.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More